The Sanofi Protein Sciences team is being recognized for their extensive engagement with federal and state legislators. When Connecticut Gov. Lamont was newly elected, the team hosted him and Lt. Gov. Bysiewicz at their Connecticut site to learn about the research and development on the COVID-19 vaccine and their flu vaccine innovative technology. Since that visit, the Governor has been a strong advocate urging residents to get a flu shot during the COVID-19 pandemic. In addition to hosting the Meriden state legislators at their site, they secured the testimony by Indresh Srivastava, Head of Process and Analytical Development, Protein Sciences, before the Connecticut Joint Health Committee to oppose HB 6447, the Governor’s bill on drug pricing that would stifle innovation.